Precision Molecular Pathology of Lung Cancer

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Cagle, Philip T. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Allen, Timothy Craig (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Beasley, Mary Beth (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Chirieac, Lucian R. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Dacic, Sanja (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Borczuk, Alain C. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Kerr, Keith M. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Sholl, Lynette M. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Portier, Bryce (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Bernicker, Eric H. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2018.
• Έκδοση: 2nd ed. 2018.
• Σειρά: Molecular Pathology Library,
• Θέματα: Pathology.; Oncology .; Thoracic surgery.; Oncology.; Thoracic Surgery.

 This new edition provides the latest information and insights into the molecular basis for lung cancer. Since the publication of the previous edition of this volume, dramatic changes have occurred with the classification of lung cancer, biomarker testing, and molecular therapy. The book covers these changes, providing updates and new insights on the background of lung cancer, testing methods, and the molecular pathology of specific cell types, including adenocarcinoma, squamous cell carcinoma, small cell carcinoma, and precursor and preinvasive lesions. Authored by experts in the field, Precision Molecular Pathology of Lung Cancer, Second Edition remains one of the few books that comprehensively covers the new molecular pathology of lung cancer and is a valuable resource for pathologists, medical oncologists, radiation oncologists, thoracic surgeons, and thoracic radiologists. 

 I. Background -- 1. Precision Medicine of Lung Cancer: Introduction -- 2. Lung Cancer Epidemiology and Demographics -- 3. Genetic Susceptibility to Lung Cancer -- 4. Lung Cancer Stem Cells -- 5. The 2015 World Health Organization Classification of Lung Cancer: Overview -- II. Testing Methods -- 6. Preanalytic considerations -- 7. Mutation testing of lung cancer biomarkers -- 8. Translocation testing of lung cancer biomarkers -- 9. Immunohistochemistry of lung cancer biomarkers -- 10. Next Generation and Third Generation Sequencing of lung cancer biomarkers -- III. Molecular Pathology of Specific Cell Types -- 11. Mutations as Predictive Biomarkers for Adenocarcinoma -- 12. Translocations as predictive Biomarkers for Adenocarcinoma -- 13. Predictive Biomarkers for Squamous Cell Carcinoma -- 14. Molecular Pathology of Small Cell Carcinoma -- 15. Molecular Pathology of Uncommon Carcinomas -- 16. Molecular Pathology of Lung Cancer Metastases -- 17. Molecular Pathology of Precursor and Preinvasive Lesions -- IV. General and Emerging Fields in Molecular Pathology of Lung Cancer -- 18. Prognostic biomarkers in lung cancer -- 19. Biomarkers and Differing Therapy Modalities -- 20. Immuno-oncology of Lung Cancer -- 21. Liquid Biopsy.